JP6829550B2 - How to use anti-obesity foods and carob powder - Google Patents

How to use anti-obesity foods and carob powder Download PDF

Info

Publication number
JP6829550B2
JP6829550B2 JP2016087619A JP2016087619A JP6829550B2 JP 6829550 B2 JP6829550 B2 JP 6829550B2 JP 2016087619 A JP2016087619 A JP 2016087619A JP 2016087619 A JP2016087619 A JP 2016087619A JP 6829550 B2 JP6829550 B2 JP 6829550B2
Authority
JP
Japan
Prior art keywords
carob
obesity
powder
food
carob powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016087619A
Other languages
Japanese (ja)
Other versions
JP2017195787A (en
Inventor
重夫 佐々木
重夫 佐々木
幸吉 林田
幸吉 林田
拓実 薗田
拓実 薗田
Original Assignee
株式会社タイショーテクノス
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社タイショーテクノス filed Critical 株式会社タイショーテクノス
Priority to JP2016087619A priority Critical patent/JP6829550B2/en
Publication of JP2017195787A publication Critical patent/JP2017195787A/en
Application granted granted Critical
Publication of JP6829550B2 publication Critical patent/JP6829550B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)

Description

本発明は、抗肥満食品、及びカロブパウダーの使用方法に関する。 The present invention relates to anti-obesity foods and methods of using carob powder.

近年、特に先進国において、肥満人口の増加が深刻な社会問題となっている。肥満は、生活習慣病であるとともに、高脂血症や糖尿病等の生活習慣病を引き起こす要因ともなりうる。このため、肥満人口の増加によって生活習慣病の患者も増加する傾向にある。また、健康上の理由だけでなく、美容上の理由からも肥満の解消が強く要望されている。 In recent years, the increase in the obese population has become a serious social problem, especially in developed countries. Obesity is a lifestyle-related disease and can be a factor that causes lifestyle-related diseases such as hyperlipidemia and diabetes. Therefore, the number of patients with lifestyle-related diseases tends to increase as the obese population increases. In addition, there is a strong demand for the elimination of obesity not only for health reasons but also for cosmetic reasons.

肥満とは、体脂肪が体内に過剰に蓄積した状態をいう。体内の体脂肪を減少させるための方法としては、食事療法や運動療法等を挙げることができる。但し、食事療法は厳格に実施する必要があり、過度の食事制限等はかえって健康を害する可能性がある。また、運動療法は長期間にわたって継続的に実施する必要がある。このため、多忙な現代社会においては継続的に実施することが困難な場合が多く、必ずしも容易な方法であるとは言えない。 Obesity is a condition in which body fat is excessively accumulated in the body. Examples of the method for reducing body fat in the body include diet therapy and exercise therapy. However, diet therapy must be strictly implemented, and excessive dietary restrictions may adversely affect health. In addition, exercise therapy needs to be performed continuously over a long period of time. For this reason, it is often difficult to carry out continuously in a busy modern society, and it is not always an easy method.

そこで、手軽で安全に摂取可能な、肥満を抑制しうる天然物質を見出すことが近年要望されている。例えば、真珠層を有する貝殻の粉末やカエデ属に属する植物の抽出物等を用いた抗肥満食品が提案されている(特許文献1及び2)。 Therefore, in recent years, there has been a demand for finding a natural substance that can be easily and safely ingested and that can suppress obesity. For example, anti-obesity foods using powdered shells having nacre and extracts of plants belonging to the genus Maple have been proposed (Patent Documents 1 and 2).

ところで、機能性を有する天然の食材として、カロブパウダーが知られている。カロブパウダーは、主として地中海付近で栽培されるカロブビーン(イナゴマメ)の鞘(果肉)を乾燥させ、粉末状に加工した食材であり、ココアパウダーの代替品等として用いられている。そして、カロブパウダーの食材としての機能としては、胃腸管等の炎症性疾患を低減しうる抗炎症性(特許文献3)や、加齢等の原因となる組織の酸化を抑制しうる抗酸化性(非特許文献1)等が知られている。 By the way, carob powder is known as a natural food material having functionality. Carob powder is an ingredient obtained by drying the pods (flesh) of carob beans (carob beans) cultivated mainly in the vicinity of the Mediterranean Sea and processing them into powder, and is used as a substitute for cocoa powder. The functions of carob powder as a food material include anti-inflammatory properties that can reduce inflammatory diseases such as the gastrointestinal tract (Patent Document 3) and antioxidant properties that can suppress the oxidation of tissues that cause aging and the like. (Non-Patent Document 1) and the like are known.

特開2006−143614号公報Japanese Unexamined Patent Publication No. 2006-143614 特開2009−268452号公報JP-A-2009-268452 特開2003−339352号公報Japanese Unexamined Patent Publication No. 2003-339352

Kumazawa et al., "Antioxidant Activity of Polyphenols in Carob Pods" Journal of Agricultural and Food Chemistry, 2002, Vol.50, No.2, p.373-377Kumazawa et al., "Antioxidant Activity of Polyphenols in Carob Pods" Journal of Agricultural and Food Chemistry, 2002, Vol.50, No.2, p.373-377

しかしながら、特許文献1及び2で提案された抗肥満食品は、その抗肥満性が必ずしも十分に高いとはいえず、さらなる改善の余地があった。また、特許文献3及び非特許文献1においては、カロブパウダーが抗肥満性を有する食材であることについて何ら報告されていない。 However, the anti-obesity foods proposed in Patent Documents 1 and 2 are not always sufficiently high in anti-obesity property, and there is room for further improvement. Further, in Patent Document 3 and Non-Patent Document 1, there is no report that carob powder is a food material having anti-obesity property.

本発明は、このような従来技術の有する問題点に鑑みてなされたものであり、その課題とするところは、食材としての汎用性が高く、優れた抗肥満性を有する抗肥満食品を提供することにある。また、本発明の課題とするところは、優れた抗肥満性を有する抗肥満食品を提供することが可能なカロブパウダーの使用方法を提供することにある。 The present invention has been made in view of the problems of the prior art, and the subject thereof is to provide an anti-obesity food having high versatility as a food material and having excellent anti-obesity. There is. Another object of the present invention is to provide a method for using carob powder, which can provide an anti-obesity food having excellent anti-obesity.

本発明者らは上記課題を解決すべく鋭意検討した結果、以下の構成とすることによって上記課題を解決することが可能であることを見出し、本発明を完成するに至った。すなわち、本発明によれば、以下に示す抗肥満商品が提供される
[1焙煎カロブパウダーを有効成分として含有し、記焙煎カロブパウダーが、イナゴマメの鞘の部分を120〜180℃で30分以上45分未満焙煎した後、粉砕して調製したものであり、脂肪細胞内に蓄積される脂肪滴を縮小させて脂肪細胞の肥大化を抑さえ、肥満を抑制する抗肥満食品。
As a result of diligent studies to solve the above problems, the present inventors have found that the above problems can be solved by adopting the following configuration, and have completed the present invention. That is, according to the present invention, the following anti-obesity products are provided .
[1] contains roasted carob powder as an active ingredient, which pre Kiabu roast carob powder, after roasting less than 45 minutes 30 minutes or more at 120 to 180 ° C. The portion of the sheath of the carob, was prepared by grinding der is, SomosomoSae the enlargement of the fat cells by reducing the fat droplets are accumulated in the fat cells, an anti-obesity food suppress obesity.

また、本発明によれば、以下に示すカロブパウダーの使用方法が提供される
[2焙煎カロブパウダーを食品に配合して、前記食品に、脂肪細胞内に蓄積される脂肪滴を縮小させて脂肪細胞の肥大化を抑さえ、肥満を抑制する抗肥満作用を付与する方法であり、記焙煎カロブパウダーが、イナゴマメの鞘の部分を120〜180℃で30分以上45分未満焙煎した後、粉砕して調製したものであるカロブパウダーの使用方法。
Further, according to the present invention, the following methods of using carob powder are provided .
[2 ] Roasted carob powder is added to a food to impart an anti-obesity effect to the food by reducing fat droplets accumulated in adipocytes to suppress adipocyte enlargement and suppressing obesity. a method, before Kiabu decoction carob powder, after partial roasting below 120 to 180 ° C. 45 minutes 30 minutes or more at the sheath of the carob, using the der Luke Rob powder that prepared by grinding.

本発明によれば、食材としての汎用性が高く、優れた抗肥満性を有する抗肥満食品を提供することができる。また、本発明によれば、優れた抗肥満性を有する抗肥満食品を提供することが可能なカロブパウダーの使用方法を提供することができる。 According to the present invention, it is possible to provide an anti-obesity food having high versatility as a food material and having excellent anti-obesity. Further, according to the present invention, it is possible to provide a method of using carob powder which can provide an anti-obesity food having excellent anti-obesity.

脂肪前駆細胞分化誘導試験の結果を示すグラフである。It is a graph which shows the result of the adipose progenitor cell differentiation induction test. 脂肪前駆細胞分化誘導試験の結果を示すグラフである。It is a graph which shows the result of the adipose progenitor cell differentiation induction test. ラジカル消去試験の結果を示すグラフである。It is a graph which shows the result of the radical scavenging test. 一酸化窒素産生試験の結果を示すグラフである。It is a graph which shows the result of the nitric oxide production test.

以下、本発明の実施の形態について説明するが、本発明は以下の実施の形態に限定されるものではない。本発明の抗肥満食品は、カロブパウダーを有効成分として含有する。以下、その詳細について説明する。 Hereinafter, embodiments of the present invention will be described, but the present invention is not limited to the following embodiments. The anti-obesity food of the present invention contains carob powder as an active ingredient. The details will be described below.

カロブパウダーは、カロブビーン(イナゴマメ)の鞘(果肉)の部分を乾燥した後、粉末化することで得られる食材である。カロブパウダーは、食物繊維やカルシウムを多く含むとともに、脂質の含有量が少なく、かつ、カフェインやテオブロミン等の刺激物を含まない食品素材として知られている。さらに、カロブパウダーは、特有の甘味及び香りを有するとともに、僅かに茶色を呈する食品素材であることから、従来、ココア(カカオ)パウダーの代替品として、チョコレート風味の食品等を製造するための材料として用いられることが知られている。 Carob powder is an ingredient obtained by drying the pod (flesh) of carob bean (carob bean) and then pulverizing it. Carob powder is known as a food material containing a large amount of dietary fiber and calcium, a low content of lipid, and no stimulants such as caffeine and theobromine. Further, since carob powder is a food material having a peculiar sweetness and aroma and slightly brownish, it is a material for producing chocolate-flavored foods and the like as a substitute for cocoa (cacao) powder. It is known to be used as.

本発明者らは、鋭意検討の結果、カロブパウダーが抗肥満性を有することを見出した。ここで、本明細書における「抗肥満性」とは、脂肪細胞内に蓄積される脂肪滴を縮小させて脂肪細胞の肥大化を抑さえ、肥満を抑制する性質を意味する。カロブパウダーが有するこのような抗肥満性は、本発明者らがはじめて見出した、従来知られていなかった機能である。このような機能を有するカロブパウダーを用いることで、食品に抗肥満性を付与し、抗肥満性を有する本発明の抗肥満食品とすることができる。 As a result of diligent studies, the present inventors have found that carob powder has anti-obesity properties. Here, the term "anti-obesity" as used herein means a property of suppressing obesity by reducing fat droplets accumulated in adipocytes and suppressing hypertrophy of adipocytes. Such anti-obesity property of carob powder is a previously unknown function discovered by the present inventors for the first time. By using carob powder having such a function, it is possible to impart anti-obesity to the food and obtain the anti-obesity food of the present invention having anti-obesity.

また、前述の通り、カロブパウダーは、抗炎症性及び抗酸化性を有する食材でもある。このため、カロブパウダーを有効成分として含有する抗肥満食品は、抗肥満性とともに、抗炎症性及び抗酸化性をもさらに兼ね備えた高機能性食品である。 In addition, as described above, carob powder is also a food material having anti-inflammatory and antioxidant properties. Therefore, the anti-obesity food containing carob powder as an active ingredient is a highly functional food having anti-obesity as well as anti-inflammatory and antioxidant properties.

カロブパウダーとしては、カロブビーンの鞘の部分を乾燥した後、粉末化した、いわゆる生の(未焙煎の)カロブパウダーの他、生のカロブパウダーを焙煎した焙煎カロブパウダーを用いることができる。焙煎カロブパウダーは、焙煎条件の相違(焙煎の程度の相違)により、例えば、カロブパウダーLight(浅煎り)、カロブパウダーDark(中煎り)、及びカロブパウダーExtra Dark(深煎り)等に分類することができる。なお、焙煎条件の相違(焙煎の程度の相違)により、得られる焙煎カロブパウダーに含まれる機能性成分の組成は異なることが推測されるが、そのような各成分の組成等を特定することは実質的に困難である。 As the carob powder, roasted carob powder obtained by roasting raw carob powder can be used in addition to so-called raw (unroasted) carob powder, which is powdered after drying the pod of carob bean. .. Depending on the roasting conditions (difference in the degree of roasting), the roasted carob powder can be used in, for example, carob powder Light (light roasting), carob powder Dark (medium roasting), carob powder Extra Dark (deep roasting), etc. Can be categorized. It is presumed that the composition of the functional components contained in the obtained roasted carob powder differs due to the difference in roasting conditions (difference in the degree of roasting), but the composition of each such component is specified. It is practically difficult to do.

本発明の抗肥満食品に有効成分として含まれるカロブパウダーは、焙煎カロブパウダーであることが好ましい。また、焙煎カロブパウダーとしては、カロブパウダーLight(浅煎り)が好ましい。焙煎カロブパウダー、なかでも浅煎りの焙煎カロブパウダー(カロブパウダーLight)を用いることで、得られる抗肥満食品の抗肥満性をより高めることができる。 The carob powder contained as an active ingredient in the anti-obesity food of the present invention is preferably roasted carob powder. Further, as the roasted carob powder, carob powder Light (light roasting) is preferable. By using roasted carob powder, especially lightly roasted roasted carob powder (carob powder Light), the anti-obesity property of the obtained anti-obesity food can be further enhanced.

本発明の抗肥満食品に含有させるカロブパウダーの量は、食品の種類や目的等に応じて適宜設定することができる。具体的には、抗肥満食品中のカロブパウダーの量は、抗肥満食品全体を基準として、5〜30質量%程度であればよい。カロブパウダーの含有量が5質量%未満であると、抗肥満性が不足する場合がある。一方、カロブパウダーの含有量が30質量%を超えると、食品の味に実質的な影響が生じやすくなることがある。 The amount of carob powder contained in the anti-obesity food of the present invention can be appropriately set according to the type and purpose of the food. Specifically, the amount of carob powder in the anti-obesity food may be about 5 to 30% by mass based on the entire anti-obesity food. If the content of carob powder is less than 5% by mass, anti-obesity may be insufficient. On the other hand, if the content of carob powder exceeds 30% by mass, the taste of food may be substantially affected.

本発明の抗肥満食品は優れた抗肥満性を有することから、抗肥満、ダイエット、抗高中性脂肪血症、抗動脈硬化等の効果を得ることを目的とした、特定保健用食品、機能性食品、栄養補助食品、健康食品等として有用である。このような食品を日常的に摂取することでその効果を発揮することが期待される。 Since the anti-obesity food of the present invention has excellent anti-obesity properties, it is a food for specified health use and functionality aimed at obtaining effects such as anti-obesity, diet, anti-hypertriglyceridemia, and anti-arteriosclerosis. It is useful as food, nutritional supplement, health food, etc. It is expected that the effect will be exhibited by ingesting such foods on a daily basis.

本発明の抗肥満食品の具体的な実施形態(食品の例)としては、パン、ケーキ等の小麦粉製品やその生地等;米飯類;スナック、ビスケット、クッキー、チョコレート、キャンディー、アイスクリーム、まんじゅう等の菓子類;ハム、ソーセージ等の加工肉製品;かまぼこ、ちくわ等の水産練り製品;粉乳、お茶、水、酒類、果汁、牛乳、その他の清涼飲料水等の飲料;等を挙げることができる。 Specific embodiments (food examples) of the anti-obesity food of the present invention include flour products such as bread and cake and their dough; rice and rice; snacks, biscuits, cookies, chocolate, sweets, ice cream, manju and the like. Confectionery; processed meat products such as ham and sausage; marine products such as kamaboko and chikuwa; beverages such as milk powder, tea, water, liquor, fruit juice, milk, and other soft drinks; and the like.

本発明の抗肥満食品には、本発明の効果を損なわない範囲で、必要に応じて、種々の添加剤を配合することができる。添加剤の具体例としては、賦形剤、pH調整剤、清涼化剤、懸濁化剤、消泡剤、粘稠剤、溶解補助剤、崩壊剤、結合剤、滑沢剤、コーティング剤、着色剤、矯味矯臭剤、界面活性剤、可塑剤、ミネラル、ビタミン、香料等を挙げることができる。 Various additives can be added to the anti-obesity food of the present invention, if necessary, as long as the effects of the present invention are not impaired. Specific examples of additives include excipients, pH adjusters, refreshing agents, suspending agents, defoaming agents, thickeners, solubilizing agents, disintegrants, binders, lubricants, coating agents, etc. Colorants, flavoring agents, surfactants, plasticizers, minerals, vitamins, fragrances and the like can be mentioned.

以下、本発明を実施例に基づいて具体的に説明するが、本発明はこれらの実施例に限定されるものではない。なお、実施例、比較例中の「部」及び「%」は、特に断らない限り質量基準である。 Hereinafter, the present invention will be specifically described based on examples, but the present invention is not limited to these examples. In addition, "part" and "%" in Examples and Comparative Examples are based on mass unless otherwise specified.

<カロブパウダーの用意>
スペイン原産のイナゴマメ(Ceratonia siliqua)の鞘(果肉)の部分を120〜180℃に設定したオーブンに入れて30分焙煎した。その後、粉砕して、焙煎カロブパウダー(カロブパウダーLight)を調製した。また、焙煎時間を45分及び60分としたこと以外は、上記のカロブパウダーLightの場合と同様にして、焙煎カロブパウダーであるカロブパウダーDark及びカロブパウダーExtra Darkをそれぞれ調製した。さらに、乾燥したイナゴマメの鞘(果肉)の部分を焙煎することなく粉砕して、未焙煎のカロブパウダーを調製した。以降、未焙煎のカロブパウダーを「カロブR」と記す。さらに、焙煎して得たカロブパウダーLight、カロブパウダーDark、及びカロブパウダーExtra Darkを、それぞれ「カロブL」、「カロブD」、及び「カロブE」と記す。
<Preparation of carob powder>
The pods (flesh) of Ceratonia siliqua native to Spain were placed in an oven set at 120-180 ° C and roasted for 30 minutes. Then, it was pulverized to prepare roasted carob powder (carob powder Light). Further, the carob powder Dark and the carob powder Extra Dark, which are roasted carob powders, were prepared in the same manner as in the case of the carob powder Light described above, except that the roasting time was set to 45 minutes and 60 minutes, respectively. Further, the dried carob pod (flesh) was crushed without roasting to prepare unroasted carob powder. Hereinafter, unroasted carob powder will be referred to as "carob R". Further, the carob powder Light, the carob powder Dark, and the carob powder Extra Dark obtained by roasting are referred to as "carob L", "carob D", and "carob E", respectively.

<活性評価用サンプルの調製>
調製した4種類のカロブパウダー(カロブR、L、D、及びE)500mg、及び市販のココアパウダー(ココアB及びH)500mgにメタノール10mLをそれぞれ加え、超音波をかけて30分間抽出した。静置後に上清をろ過した。残渣に80%メタノール10mLをそれぞれ加え、超音波をかけて30分間抽出した。静置後に上清をろ過し、先にろ過して得た上清と混合して抽出液とした。エバポレータを用いて得られた抽出液から溶媒を除去し、それぞれのメタノール抽出物を得た。得られたメタノール抽出物に水0.5mLをそれぞれ加えて懸濁した後、コンディショニング及び平衡化済みのカラム(商品名「Sep−Pak C18」、日本ウォーターズ社製)に供した。水0.5mL(2回)で洗浄後、メタノール0.5mLで溶出させて溶出液を得た。エバポレータを用いて得られた溶出液から溶媒を除去し、乾固物(抽出物)を得た。得られた抽出物のそれぞれにジメチルスルフォキシド(DMSO)を添加し、抽出物の濃度が100mg/mLである活性評価用サンプルを調製した。
<Preparation of sample for activity evaluation>
To 500 mg of the prepared four types of carob powder (carob R, L, D, and E) and 500 mg of commercially available cocoa powder (cocoa B and H), 10 mL of methanol was added, and the mixture was extracted with ultrasonic waves for 30 minutes. The supernatant was filtered after standing. 10 mL of 80% methanol was added to the residue, and the mixture was extracted with ultrasonic waves for 30 minutes. After standing, the supernatant was filtered and mixed with the supernatant obtained by filtering first to prepare an extract. The solvent was removed from the extract obtained using an evaporator to obtain each methanol extract. 0.5 mL of water was added to each of the obtained methanol extracts to suspend the mixture, and the mixture was subjected to a conditioned and equilibrated column (trade name “Sep-Pak C18”, manufactured by Japan Waters Corp.). After washing with 0.5 mL of water (twice), the mixture was eluted with 0.5 mL of methanol to obtain an eluate. The solvent was removed from the eluate obtained by using an evaporator to obtain a dry matter (extract). Dimethyl sulfoxide (DMSO) was added to each of the obtained extracts to prepare a sample for activity evaluation having a concentration of the extract of 100 mg / mL.

<脂肪前駆細胞分化誘導試験>
マウス由来の前駆脂肪細胞(3T3−L1)を1×104cells/wellとなるように96穴プレートのウェルに100μLずつ入れ、37℃、5%CO2のインキュベータ内で2日間培養した。DMEM培地に、3−イソブチルメチルキサンチン(IBMX)及びデキサメタゾン(Dex)をそれぞれ0.5mM及び0.1μMとなるように添加して分化誘導培地を調製した。調製した分化誘導培地に活性評価用サンプルを添加し、25、50、及び100μg/mLの希釈系列をそれぞれの活性評価用サンプルについて作製した。96穴プレートのウェル内の培地を除去し、活性評価用サンプルを含む分化誘導培地を100μLずつ加えた後、37℃、5%CO2のインキュベータ内で2日間培養した。なお、活性評価用サンプルを含まない分化誘導培地のみを100μLずつ加えたものを未処理のウェルとして培養した。
<Adipose progenitor cell differentiation induction test>
Mouse-derived preadipocytes (3T3-L1) were placed in 100 μL wells of 96-well plates at 1 × 10 4 cells / well and cultured at 37 ° C. in a 5% CO 2 incubator for 2 days. Differentiation-inducing medium was prepared by adding 3-isobutylmethylxanthine (IBMX) and dexamethasone (Dex) to DMEM medium at 0.5 mM and 0.1 μM, respectively. Samples for activity evaluation were added to the prepared differentiation-inducing medium, and dilution series of 25, 50, and 100 μg / mL were prepared for each sample for activity evaluation. The medium in the wells of the 96-well plate was removed, 100 μL of the differentiation-inducing medium containing the sample for activity evaluation was added, and the cells were cultured in an incubator at 37 ° C. and 5% CO 2 for 2 days. In addition, only the differentiation-inducing medium containing no sample for activity evaluation was added in an amount of 100 μL each, and the cells were cultured as untreated wells.

DMEM培地にインスリン(insulin)を0.1μg/mLとなるように添加して分化維持培地を調製した。調製した分化維持培地に活性評価用サンプルを添加し、25、50、及び100μg/mLの希釈系列をそれぞれの活性評価用サンプルについて作製した。96穴プレートのウェル内の培地を除去し、活性評価用サンプルを含む分化誘導培地を100μLずつ加えた後、37℃、5%CO2のインキュベータ内で3日間培養した。なお、未処理のウェルには、活性評価用サンプルを含まない分化維持培地のみを100μLずつ加えて培養した。3日間培養後に同じ操作を行い、37℃、5%CO2のインキュベータ内で3日間培養した後、以下に示すWST−8法及びOil Red O法により細胞生存率及び脂肪蓄積率をそれぞれ算出した。 Insulin was added to DMEM medium at a concentration of 0.1 μg / mL to prepare a differentiation maintenance medium. Samples for activity evaluation were added to the prepared differentiation maintenance medium, and dilution series of 25, 50, and 100 μg / mL were prepared for each sample for activity evaluation. The medium in the wells of the 96-well plate was removed, 100 μL of the differentiation-inducing medium containing the sample for activity evaluation was added, and the cells were cultured in an incubator at 37 ° C. and 5% CO 2 for 3 days. In the untreated wells, only 100 μL of the differentiation maintenance medium containing no sample for activity evaluation was added and cultured. After culturing for 3 days, the same operation was performed, and after culturing in an incubator at 37 ° C. and 5% CO 2 for 3 days, the cell viability and fat accumulation rate were calculated by the WST-8 method and the Oil Red O method shown below, respectively. ..

(細胞生存率)
PBSにWST−8が2%となるように添加して調製したWST−8/PBS溶液を、培地を除去した96穴プレートのウェル内に100μLずつ加えた。37℃、5%CO2のインキュベータ内で3時間培養した後、吸光プレートリーダーを使用して、450nmにおける吸光度を測定した。未処理のウェルの吸光度の値を100%として、測定した吸光度の値から各活性評価用サンプルで処理した細胞の「細胞生存率(%)」を算出した。なお、試験はn=3で行った。結果を図1及び2に示す。
(Cell viability)
The WST-8 / PBS solution prepared by adding WST-8 to PBS at 2% was added in 100 μL each into the wells of the 96-well plate from which the medium had been removed. After culturing in an incubator at 37 ° C. and 5% CO 2 for 3 hours, the absorbance at 450 nm was measured using an absorption plate reader. The "cell viability (%)" of the cells treated with each activity evaluation sample was calculated from the measured absorbance values, assuming that the absorbance value of the untreated well was 100%. The test was performed with n = 3. The results are shown in FIGS. 1 and 2.

(脂肪蓄積率)
96穴プレートの各ウェルからWST−8/PBS溶液を除去するとともに、ホルマリンを100μLずつ添加した後、4℃で一晩静置した。ホルマリンを除去するとともに、60%イソプロパノール水溶液100μLを添加し、細胞を洗浄した後にイソプロパノール水溶液を除去した。Oil Red O溶液(5mg/mL Oil Red O in イソプロパノール:水=6:4)100μLを各ウェルに添加し、室温で10分間静置した後、Oil Red O溶液を除去した。超純水100μLを加えて洗浄する洗浄操作を3回行った後、超純水を完全に除去した。イソプロパノール100μLを各ウェルに添加し、3分間振とうした後、吸光プレートリーダーを使用して、520nmにおける吸光度を測定した。未処理のウェルの吸光度の値を100%として、測定した吸光度の値から各活性評価用サンプルで処理した細胞の「脂肪蓄積率(%)」を算出した。なお、試験はn=3で行った。結果を図1及び2に示す。
(Fat accumulation rate)
The WST-8 / PBS solution was removed from each well of the 96-well plate, 100 μL of formalin was added, and the mixture was allowed to stand overnight at 4 ° C. Formalin was removed, 100 μL of a 60% isopropanol aqueous solution was added, the cells were washed, and then the isopropanol aqueous solution was removed. 100 μL of Oil Red O solution (5 mg / mL Oil Red O in isopropanol: water = 6: 4) was added to each well, allowed to stand at room temperature for 10 minutes, and then the Oil Red O solution was removed. After performing the washing operation of adding 100 μL of ultrapure water three times, the ultrapure water was completely removed. After adding 100 μL of isopropanol to each well and shaking for 3 minutes, the absorbance at 520 nm was measured using an absorption plate reader. Assuming that the absorbance value of the untreated well was 100%, the "fat accumulation rate (%)" of the cells treated with each activity evaluation sample was calculated from the measured absorbance value. The test was performed with n = 3. The results are shown in FIGS. 1 and 2.

(脂肪前駆細胞分化誘導試験の結果)
図1及び2に示すように、カロブR、カロブL、及びカロブDの活性評価用サンプルを用いた場合には、対象区としたヘスペレチンを用いた場合(12.5、25、及び50μg/mL)と同様に、有効な細胞蓄積率の低下が認められた。なお、カロブLの活性評価用サンプルを各濃度で用いた細胞を顕微鏡で観察したところ、細胞内における脂肪滴の減少を確認することができた。また、いずれのサンプルについても、脂肪前駆細胞に対する細胞毒性は認められなかった(細胞生存率>80%)。一方、ココアB及びココアHの活性評価用サンプルを用いた場合には、有効な細胞蓄積率の低下が認められないことが判明した(図2)。
(Results of adipose progenitor cell differentiation induction test)
As shown in FIGS. 1 and 2, when the sample for evaluating the activity of carob R, carob L, and carob D was used, when the target hesperetin was used (12.5, 25, and 50 μg / mL). ), A decrease in the effective cell accumulation rate was observed. When the cells using the carob L activity evaluation sample at each concentration were observed under a microscope, a decrease in intracellular lipid droplets could be confirmed. In addition, no cytotoxicity to adipose progenitor cells was observed in any of the samples (cell viability> 80%). On the other hand, it was found that no decrease in the effective cell accumulation rate was observed when the samples for evaluating the activity of cocoa B and cocoa H were used (Fig. 2).

<ラジカル消去試験>
2,2−diphenyl−1−picrylhydrazyl(DPPH)をエタノールに溶解し、0.1mMのDPPH溶液を調製した。一方、エタノールを用いて、50、100、及び200μg/mLの各活性評価用サンプルの希釈系列を調製した(最終濃度25、50、及び100μg/mL)。調製した各活性評価用サンプルの希釈系列をそれぞれ100μLずつ96穴プレートのウェルに入れるとともに、DPPH溶液を100μLずつさらに入れ、ボルテックスミキサーを用いて撹拌した。96穴プレートをアルミホイルで遮光し、室温で30分間静置した後、吸光プレートリーダーを使用して、517nmにおける吸光度を測定した。未処理のウェルの吸光度の値を100%として、測定した吸光度の値から各活性評価用サンプルの「DPPHラジカル消去率(%)」を算出した。なお、試験はn=3で行った。結果を図3に示す。
<Radical scavenging test>
2,2-diphenyl-1-picrylydrazyl (DPPH) was dissolved in ethanol to prepare a 0.1 mM DPPH solution. Meanwhile, ethanol was used to prepare dilution series of 50, 100, and 200 μg / mL activity evaluation samples (final concentrations 25, 50, and 100 μg / mL). A dilution series of 100 μL of each prepared sample for activity evaluation was put into a well of a 96-well plate, and another 100 μL of DPPH solution was put into the well, and the mixture was stirred using a vortex mixer. The 96-well plate was shielded from light with aluminum foil and allowed to stand at room temperature for 30 minutes, and then the absorbance at 517 nm was measured using an absorption plate reader. The "DPPH radical scavenging rate (%)" of each activity evaluation sample was calculated from the measured absorbance value, assuming that the absorbance value of the untreated well was 100%. The test was performed with n = 3. The results are shown in FIG.

(ラジカル消去試験の結果)
図3に示すように、すべての活性評価用サンプルにおいて濃度に依存したDPPHラジカル消去活性が認められた。
(Result of radical scavenging test)
As shown in FIG. 3, concentration-dependent DPPH radical scavenging activity was observed in all activity evaluation samples.

<一酸化窒素産生試験>
マウスマクロファージ様細胞(J774.1)を1×105cells/wellとなるように96穴プレートのウェルに100μLずつ入れ、37℃、5%CO2のインキュベータ内で一晩培養した。RPMI−1640培地に、リポポリサッカライド(LPS)を20μg/mLとなるように添加して培地を調製した。調製した培地に活性評価用サンプルを添加し、50、100、及び200μg/mLの希釈系列をそれぞれの活性評価用サンプルについて作製した(最終濃度25、50、及び100μg/mL)。培養後の96穴プレートのウェルに活性評価用サンプルを含む培地を100μLずつ加えた(総量200μL)後、37℃、5%CO2のインキュベータ内で1日間培養した。なお、活性評価用サンプルを含まない培地のみを100μLずつ加えたものを未処理のウェルとして培養した。1日間培養後、以下に示すグリース試薬法及びMTT法により一酸化窒素産生率及び細胞生存率をそれぞれ算出した。
<Nitric oxide production test>
Mouse macrophage-like cells (J774.1) were placed in wells of 96-well plates at 1 × 10 5 cells / well in 100 μL portions and cultured overnight in an incubator at 37 ° C. and 5% CO 2 . The medium was prepared by adding lipopolysaccharide (LPS) to RPMI-1640 medium at a concentration of 20 μg / mL. Activity evaluation samples were added to the prepared medium, and dilution series of 50, 100, and 200 μg / mL were prepared for each activity evaluation sample (final concentrations 25, 50, and 100 μg / mL). After 100 μL of the medium containing the sample for activity evaluation was added to the wells of the 96-well plate after culturing (total amount 200 μL), the cells were cultured in an incubator at 37 ° C. and 5% CO 2 for 1 day. In addition, only the medium containing no sample for activity evaluation was added by 100 μL each, and the mixture was cultured as an untreated well. After culturing for 1 day, the nitric oxide production rate and the cell viability were calculated by the grease reagent method and the MTT method shown below, respectively.

(一酸化窒素産生率)
新たな96穴プレートのウェルにグリース試薬(1%スルファニルアミド、0.1%N−1−ナフチルエチレンジアミン、2.5%リン酸、及び超純水)を100μLずつ入れた。培養した培地上清100μLを加え、室温で20分静置した後、吸光プレートリーダーを使用して550nmにおける吸光度を測定した。未処理のウェルの吸光度の値を100%として、測定した吸光度の値から各活性評価用サンプルで処理した細胞の「一酸化窒素産生率(%)」を算出した。なお、試験はn=3で行った。結果を図4に示す。
(Nitric oxide production rate)
The wells of the new 96-well plate were filled with 100 μL of grease reagents (1% sulfanilamide, 0.1% N-1-naphthylethylenediamine, 2.5% phosphoric acid, and ultrapure water). After adding 100 μL of the cultured medium supernatant and allowing it to stand at room temperature for 20 minutes, the absorbance at 550 nm was measured using an absorption plate reader. Assuming that the absorbance value of the untreated well was 100%, the "nitric oxide production rate (%)" of the cells treated with each activity evaluation sample was calculated from the measured absorbance value. The test was performed with n = 3. The results are shown in FIG.

(細胞生存率)
培養した細胞の各ウェルから培地上清を除去し、5mg/mL MTT溶液が5μL入るように調製したMTT/PBS溶液を100μLずつ加え、37℃、5%CO2のインキュベータ内で3時間培養した。3時間培養後、上清を除去し、ジメチルスルフォキシド100μLを加えて細胞内のホルマザンを溶解させた。吸光プレートリーダーを使用して450nmにおける吸光度を測定した。未処理のウェルの吸光度の値を100%として、測定した吸光度の値から各活性評価用サンプルで処理した細胞の「細胞生存率(%)」を算出した。なお、試験はn=3で行った。結果を図4に示す。
(Cell viability)
The medium supernatant was removed from each well of the cultured cells, 100 μL of MTT / PBS solution prepared to contain 5 μL of 5 mg / mL MTT solution was added, and the cells were cultured in an incubator at 37 ° C. and 5% CO 2 for 3 hours. .. After culturing for 3 hours, the supernatant was removed, and 100 μL of dimethylsulfoxide was added to dissolve intracellular formazan. Absorbance at 450 nm was measured using an absorption plate reader. The "cell viability (%)" of the cells treated with each activity evaluation sample was calculated from the measured absorbance values, assuming that the absorbance value of the untreated well was 100%. The test was performed with n = 3. The results are shown in FIG.

(一酸化窒素産生試験の結果)
図4に示すように、カロブD及びカロブEの活性評価用サンプルを用いた場合、特に、カロブEの活性評価用サンプルを用いた場合に、有効な一酸化窒素産生率の低下が認められた。また、いずれのサンプルについても、マウスマクロファージ様細胞に対する細胞毒性は認められなかった(細胞生存率>86%)。
(Results of nitric oxide production test)
As shown in FIG. 4, an effective decrease in nitric oxide production was observed when the activity evaluation samples of carob D and carob E were used, especially when the activity evaluation sample of carob E was used. .. In addition, no cytotoxicity to mouse macrophage-like cells was observed in any of the samples (cell viability> 86%).

本発明の抗肥満食品は、抗肥満等の効果を得ることを目的とする機能性食品として有用である。 The anti-obesity food of the present invention is useful as a functional food for the purpose of obtaining effects such as anti-obesity.

Claims (2)

焙煎カロブパウダーを有効成分として含有し、
記焙煎カロブパウダーが、イナゴマメの鞘の部分を120〜180℃で30分以上45分未満焙煎した後、粉砕して調製したものであり、
脂肪細胞内に蓄積される脂肪滴を縮小させて脂肪細胞の肥大化を抑さえ、肥満を抑制する抗肥満食品。
Contains roasted carob powder as an active ingredient,
Before Kiabu decoction carob powder, after roasting less than 45 minutes 30 minutes or more at 120 to 180 ° C. The portion of the sheath of the carob state, and are not prepared by grinding,
An anti- obesity food that suppresses obesity by shrinking fat droplets accumulated in fat cells and suppressing hypertrophy of fat cells .
焙煎カロブパウダーを食品に配合して、前記食品に、脂肪細胞内に蓄積される脂肪滴を縮小させて脂肪細胞の肥大化を抑さえ、肥満を抑制する抗肥満作用を付与する方法であり、
記焙煎カロブパウダーが、イナゴマメの鞘の部分を120〜180℃で30分以上45分未満焙煎した後、粉砕して調製したものであるカロブパウダーの使用方法。
It is a method of blending roasted carob powder into a food to give the food an anti-obesity effect that suppresses obesity by reducing the fat droplets accumulated in the fat cells to suppress the hypertrophy of the fat cells. ,
Before Kiabu decoction carob powder, after partial roasting below 120 to 180 ° C. 45 minutes 30 minutes or more at the sheath of the carob, using the Der Luke Rob powder that prepared by grinding.
JP2016087619A 2016-04-26 2016-04-26 How to use anti-obesity foods and carob powder Active JP6829550B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2016087619A JP6829550B2 (en) 2016-04-26 2016-04-26 How to use anti-obesity foods and carob powder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2016087619A JP6829550B2 (en) 2016-04-26 2016-04-26 How to use anti-obesity foods and carob powder

Publications (2)

Publication Number Publication Date
JP2017195787A JP2017195787A (en) 2017-11-02
JP6829550B2 true JP6829550B2 (en) 2021-02-10

Family

ID=60236585

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016087619A Active JP6829550B2 (en) 2016-04-26 2016-04-26 How to use anti-obesity foods and carob powder

Country Status (1)

Country Link
JP (1) JP6829550B2 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2204301B1 (en) * 2002-08-06 2005-03-01 Investigacion Y Nutricion, S.L. Denatured carob flour (HAD) WITH LOW CONTENT IN SOLUBLE AND SUGAR TANINS, INTENDED FOR HUMAN CONSUMPTION, AND PROCEDURE FOR OBTAINING IT.
JP2005068128A (en) * 2003-08-01 2005-03-17 Soda Aromatic Co Ltd alpha-GLUCOSIDASE INHIBITOR
JP2006061117A (en) * 2004-08-30 2006-03-09 Ls Corporation:Kk Health food for dieting use
JP2009067716A (en) * 2007-09-12 2009-04-02 Unitika Ltd Manufacturing method of pinitol or pinitol-containing composition
JP2009196931A (en) * 2008-02-21 2009-09-03 Kobe Univ Antiobestic agent and food and drink using the same

Also Published As

Publication number Publication date
JP2017195787A (en) 2017-11-02

Similar Documents

Publication Publication Date Title
JP5450383B2 (en) Use of cocoa extract
JP5432123B2 (en) Novel use of cacao extract
JP4448266B2 (en) Chillability improving agent and composition for improving cooling performance
KR20160109512A (en) Mixed tea composition with aronia, a process for the preparation thereof, and a tea-bag tea comprising the same
JP2022031912A (en) Oral composition
JP3671190B1 (en) Extract obtained from lotus plant, method for producing the extract and anti-obesity agent
JP2013075874A (en) Blood sugar metabolism improver
JP5969529B2 (en) Anti-inflammatory agent
JP6829550B2 (en) How to use anti-obesity foods and carob powder
JP2017178805A (en) Lps production inhibiting agent, and food composition for inhibiting lps production
JP6893210B2 (en) Metabolic syndrome inhibitor
JP6757995B2 (en) Oral composition
JP2019034920A (en) PDE5 activity inhibitor
JP6981641B2 (en) PDE5 activity inhibitor
JP2022124984A (en) Lipase activity inhibitor and use thereof
JP5608877B2 (en) Swelling preventive and oral composition
JP2012131760A (en) Fatty acid absorption inhibitor
JP4626081B2 (en) Pancreatic lipase inhibitor
JP2019176828A (en) Oral composition
JP7452874B2 (en) Oral composition
JP7305595B2 (en) Agent for improving mental fatigue, decreased motivation or drowsiness
JP2019034902A (en) Composition
JP2019052122A (en) Adiponectin secretion enhancer, lipid progenitor cell differentiation-promoting agent, as well as pharmaceutical compositions, foods, and feeds comprising the same
JP7232096B2 (en) Secondary bile acid production inhibitor
JP7029697B2 (en) Swallowing function improving agent

Legal Events

Date Code Title Description
RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20170425

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190403

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20200123

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200204

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200401

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200825

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201013

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210104

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210122

R150 Certificate of patent or registration of utility model

Ref document number: 6829550

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250